D D Cunningham and the aetiology of cholera in British India, 1869-1897.

Por Isaacs, J D
Publicado em 1998

Immunotherapy of rheumatoid arthritis.

Por Watts, R A, Isaacs, J D
Publicado em 1992

Tolerogenic dendritic cell therapy for rheumatoid arthritis: where are we now?

Por Hilkens, C M U, Isaacs, J D
Publicado em 2013

The role of the cellular prion protein in the immune system

Por Isaacs, J D, Jackson, G S, Altmann, D M
Publicado em 2006

Acquired factor VIII inhibitor associated with lung abscess.

Por Ganly, P S, Isaacs, J D, Laffan, M A, Haslett, C, Hows, J M
Publicado em 1987

A therapeutic human IgG4 monoclonal antibody that depletes target cells in humans

Por ISAACS, J D, WING, M G, GREENWOOD, J D, HAZLEMAN, B L, HALE, G, WALDMANN, H
Publicado em 1996

Determination of thymic function directly from peripheral blood: A validated modification to an established method()

Por Lorenzi, A.R., Patterson, A.M., Pratt, A., Jefferson, M., Chapman, C.E., Ponchel, F., Isaacs, J.D.
Publicado em 2008

Thymic function in juvenile idiopathic arthritis

Por Lorenzi, A R, Morgan, T A, Anderson, A, Catterall, J, Patterson, A M, Foster, H E, Isaacs, J D
Publicado em 2008

Corrigendum to “Determination of thymic function directly from peripheral blood: A validated modification to an established method” [J. Immunol. Methods 2008 339(2):185–94]

Por Lorenzi, A.R., Patterson, A.M., Pratt, A., Jefferson, M., Chapman, C.E., Ponchel, F., Isaacs, J.D.
Publicado em 2009

Monoclonal antibody therapy of chronic intraocular inflammation using Campath-1H.

Por Isaacs, J D, Hale, G, Waldmann, H, Dick, A D, Haynes, R, Forrester, J V, Watson, P, Meyer, P A
Publicado em 1995

Local bioactive tumour necrosis factor (TNF) in corneal allotransplantation

Por Rayner, S A, King, W J, Comer, R M, Isaacs, J D, Hale, G, George, A J T, Larkin, D F P
Publicado em 2000

Association of a complement receptor 1 gene variant with baseline erythrocyte sedimentation rate levels in patients starting anti-TNF therapy in a UK rheumatoid arthritis cohort: r...

Por Bluett, J, Ibrahim, I, Plant, D, Hyrich, K L, Morgan, A W, Wilson, A G, Isaacs, J D, Barton, A
Publicado em 2014

Humanized anti-CD4 monoclonal antibody therapy of autoimmune and inflammatory disease

Por ISAACS, J D, BURROWS, N, WING, M, KEOGAN, M T, REBELLO, P R U B, WATTS, R A, PYE, R J, NORRIS, P, HAZELMAN, B L, HALE, G, WALDMANN, H
Publicado em 1997

Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naïve with active rheumatoid arthritis an...

Por Emery, P, Deodhar, A, Rigby, W F, Isaacs, J D, Combe, B, Racewicz, A J, Latinis, K, Abud-Mendoza, C, Szczepański, L J, Roschmann, R A, Chen, A, Armstrong, G K, Douglass, W, Tyrrell, H
Publicado em 2010

Synovial CD4+ T-cell-derived GM-CSF supports the differentiation of an inflammatory dendritic cell population in rheumatoid arthritis

Por Reynolds, G, Gibbon, J R, Pratt, A G, Wood, M J, Coady, D, Raftery, G, Lorenzi, A R, Gray, A, Filer, A, Buckley, C D, Haniffa, M A, Isaacs, J D, Hilkens, C M U
Publicado no Ann Rheum Dis (2016)

Tolerogenic dendritic cells generated with dexamethasone and vitamin D3 regulate rheumatoid arthritis CD4(+) T cells partly via transforming growth factor‐β1

Por Anderson, A. E., Swan, D. J., Wong, O. Y., Buck, M., Eltherington, O., Harry, R. A., Patterson, A. M., Pratt, A. G., Reynolds, G., Doran, J.‐P., Kirby, J. A., Isaacs, J. D., Hilkens, C. M. U.
Publicado no Clin Exp Immunol (2016)